Is Pfizer Stock A Buy Or A Sell With Covid-Era Growth In The Rearview?

stock has tumbled this year as demand for Covid products wanes and amid a fresh challenge in the obesity treatment space. During the second quarter, Pfizer's sales plummeted by half and missed forecasts. Adjusted earnings also tumbled, but beat expectations by a penny. Excluding the impact of…#pfizer #novonordisk #nvo #elililly #lly #fda #hemophilia #rsv #sgen #nurtec
Source: Reuters: Health - Category: Consumer Health News Source Type: news